• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

良性前列腺梗阻患者令人烦恼的泌尿症状及疾病特异性生活质量

Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction.

作者信息

Marklund-Bau Helén, Edéll-Gustafsson Ulla, Spångberg Anders

机构信息

Department of Biomedicine and Surgery, University Hospital of Linköping, Linköping, Sweden.

出版信息

Scand J Urol Nephrol. 2007;41(1):32-41. doi: 10.1080/00365590601068926.

DOI:10.1080/00365590601068926
PMID:17366100
Abstract

OBJECTIVES

Firstly, to describe self-reported urinary symptoms and bothersomeness, including disease-specific quality of life (QOL), in patients with symptomatic benign prostatic obstruction (BPO) before and 6 months after intervention. Secondly, to identify factors which predict disease-specific QOL. Thirdly, to develop and test the reliability of an instrument to evaluate incontinence, the Linköping Incontinence Questionnaire (LIQ). Finally, to translate and test the reliability of Swedish versions of the International Prostate Symptom Score, including the bother question, the American Urological Association Symptom Problem Index (SPI) and the Benign Prostatic Hyperplasia Impact Index.

MATERIAL AND METHODS

Disease-specific QOL was studied in 572/720 consecutively treated patients using structured questionnaires. The reliability of the instruments was tested in 122 patients with lower urinary tract symptoms (LUTS) or BPO.

RESULTS

The frequency and weak stream items of the SPI were among those that best explained the patients' disease-specific QOL both before and after intervention. Before and after intervention the prevalence of urinary incontinence, assessed using the LIQ instrument, was 46% and 16%, respectively. Symptoms and disease-specific QOL improved most in the surgery group, intermediately in the transurethral incision of the prostate/transurethral microwave thermotherapy group and least in the drug therapy group.

CONCLUSIONS

The frequency and weak stream items of the SPI were the factors that best explained disease-specific QOL. The prevalence of incontinence before and after intervention was higher than that previously reported.

摘要

目的

第一,描述有症状的良性前列腺梗阻(BPO)患者在干预前及干预后6个月自我报告的泌尿系统症状及困扰程度,包括疾病特异性生活质量(QOL)。第二,确定预测疾病特异性生活质量的因素。第三,开发并测试一种评估尿失禁的工具——林雪平尿失禁问卷(LIQ)的可靠性。最后,翻译并测试瑞典语版国际前列腺症状评分(包括困扰问题)、美国泌尿外科学会症状问题指数(SPI)和良性前列腺增生影响指数的可靠性。

材料与方法

使用结构化问卷对572/720例连续接受治疗的患者进行疾病特异性生活质量研究。在122例下尿路症状(LUTS)或BPO患者中测试这些工具的可靠性。

结果

SPI的排尿频率和尿流细弱项目是干预前后最能解释患者疾病特异性生活质量的因素。使用LIQ工具评估,干预前后尿失禁的患病率分别为46%和16%。手术组症状和疾病特异性生活质量改善最为明显,前列腺经尿道切开术/经尿道微波热疗组次之,药物治疗组改善最少。

结论

SPI的排尿频率和尿流细弱项目是最能解释疾病特异性生活质量的因素。干预前后尿失禁的患病率高于先前报道。

相似文献

1
Bothersome urinary symptoms and disease-specific quality of life in patients with benign prostatic obstruction.良性前列腺梗阻患者令人烦恼的泌尿症状及疾病特异性生活质量
Scand J Urol Nephrol. 2007;41(1):32-41. doi: 10.1080/00365590601068926.
2
A Swedish version of a quality of life questionnaire for partners of men with symptoms suggestive of benign prostatic obstruction.
Scand J Urol Nephrol. 2008;42(2):126-31. doi: 10.1080/00365590701725698.
3
Relevance and variability of the severity of incontinence, and increased daytime and night-time voiding frequency, associated with quality of life in men with lower urinary tract symptoms.下尿路症状男性患者中,尿失禁严重程度的相关性和变异性,以及日间和夜间排尿频率增加与生活质量的关系。
BJU Int. 2005 Jul;96(1):83-7. doi: 10.1111/j.1464-410X.2005.05572.x.
4
Impact of surgical treatment on nocturia in men with benign prostatic obstruction.手术治疗对良性前列腺梗阻男性夜尿症的影响。
BJU Int. 2006 Oct;98(4):799-805. doi: 10.1111/j.1464-410X.2006.06380.x.
5
Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being.良性前列腺增生中下尿路症状的患病率、困扰程度及其对生活质量的影响。
J Urol. 2001 Aug;166(2):563-8.
6
Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.经尿道前列腺切除术后下尿路症状改善患者的症状、生活质量与尿动力学参数之间的关联
Neurourol Urodyn. 2008;27(3):222-5. doi: 10.1002/nau.20466.
7
Relationship between lower urinary tract symptoms frequency assessed by the IPSS and bothersomeness (SPI) among men older than 50 years old.国际前列腺症状评分(IPSS)评估的50岁以上男性下尿路症状频率与困扰程度(SPI)之间的关系。
Eur Urol. 2005 Oct;48(4):601-7. doi: 10.1016/j.eururo.2005.06.013.
8
Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' Study. International Continence Society--Benign Prostatic Hyperplasia.使用国际前列腺症状评分(ICSOoL)评估下尿路症状对生活质量的影响:来自国际尿控协会-良性前列腺增生症(ICS-‘BPH’)研究的证据。国际尿控协会-良性前列腺增生症
Br J Urol. 1997 Nov;80(5):712-21.
9
Visual analog scale questionnaire to assess quality of life specific to each symptom of the International Prostate Symptom Score.用于评估国际前列腺症状评分中每种症状特定生活质量的视觉模拟量表问卷。
J Urol. 2006 Aug;176(2):665-71. doi: 10.1016/j.juro.2006.03.031.
10
Impact on quality of life of different lower urinary tract symptoms in men measured by means of the SF 36 questionnaire.通过SF-36问卷测量不同男性下尿路症状对生活质量的影响。
Scand J Urol Nephrol. 2006;40(6):485-94. doi: 10.1080/00365590600830862.

引用本文的文献

1
The Selective α1 Antagonist Tamsulosin Alters ECM Distributions and Cellular Metabolic Functions of ARPE 19 Cells in a Concentration-Dependent Manner.选择性α1拮抗剂坦索罗辛以浓度依赖性方式改变ARPE 19细胞的细胞外基质分布和细胞代谢功能。
Bioengineering (Basel). 2022 Oct 14;9(10):556. doi: 10.3390/bioengineering9100556.
2
The health-related quality of life of Chinese patients with lower urinary tract symptoms in primary care.中国基层医疗中患有下尿路症状患者的健康相关生活质量。
Qual Life Res. 2014 Dec;23(10):2723-33. doi: 10.1007/s11136-014-0725-5. Epub 2014 Jun 12.
3
The floppy iris syndrome - what urologists and ophthalmologists need to know.
松弛性虹膜综合征——泌尿外科医生和眼科医生需要了解的内容。
Curr Urol. 2012 May;6(1):1-7. doi: 10.1159/000338861. Epub 2012 Apr 30.
4
Effect of combination treatment on patient-related outcome measures in benign prostatic hyperplasia: clinical utility of dutasteride and tamsulosin.联合治疗对良性前列腺增生患者相关结局指标的影响:度他雄胺和坦索罗辛的临床应用价值
Patient Relat Outcome Meas. 2011 Jul;2:71-9. doi: 10.2147/PROM.S13062. Epub 2011 Mar 31.
5
Measurement properties of the benign prostatic hyperplasia impact index in tadalafil studies.他达拉非研究中良性前列腺增生影响指数的测量特性。
Health Qual Life Outcomes. 2010 Nov 12;8:131. doi: 10.1186/1477-7525-8-131.
6
Role of voiding and storage symptoms for the quality of life before and after treatment in men with voiding dysfunction.排尿和储尿症状对排尿功能障碍男性治疗前后生活质量的影响。
World J Urol. 2010 Feb;28(1):3-8. doi: 10.1007/s00345-009-0480-3. Epub 2009 Oct 9.
7
Iris morphologic changes related to alpha(1)-adrenergic receptor antagonists implications for intraoperative floppy iris syndrome.与α₁-肾上腺素能受体拮抗剂相关的虹膜形态学改变对术中虹膜松弛综合征的影响
Ophthalmology. 2009 May;116(5):877-81. doi: 10.1016/j.ophtha.2008.12.040.